Skip to main content
. 2023 Nov 2;15(21):5263. doi: 10.3390/cancers15215263

Table 2.

Inhibitory effect on RPL/RPS gene expression (cpm value).

Placebo Omacetaxine Palbociclib Both Drugs CTC Clone
RPL12 2.14 1.71 4.81 7.95 11.4
RPL13 5.1 3.14 5.55 3.2 177.59
RPL18A 1 2.43 1.77 1.73 16.78
RPL19 81.1 108.64 154.07 143.33 43.91
RPL26 3.29 1.71 3.27 4.35 6.5
RPL37 15.35 15.98 22.96 6.72 73.96
RPL38 1.91 3.85 5.6 2.39 27.73
RPL7 3.29 2.42 1 1.73 15.61
RPL7A 8.72 5.27 1 1 46.48
RPS18 8.96 3.85 1.75 5.82 22.42
RPL6 3.05 1 1 1.65 7.07
RPL35A 4.62 1.71 5.57 3.78 69.09
RPL23 13.01 2.43 4.81 7.37 35.69
RPS12 60.17 48.06 33.63 81.2 17.56
RPS15A 1 1 1 1 20.35
RPS24 1 1 1.75 4.35 24.82
RPS26 1 1 1 1 3.51
RPS28 1 1 1 1 12.91
RPS5 5.1 1 2.54 9.42 15.37
RPS7 1.91 1.71 2.5 3.12 5.03
RPSA 12.39 4.56 7.09 20.05 28.92
Average 11.2 10.17 12.56 14.87 32.51